17:22 EDT AN2 Therapeutics (ANTX) files $300M mixed securities shelf
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANTX:
- AN2 Therapeutics announces initiation of Phase 2 trial of epetraborole
- AN2 Therapeutics Reprices Stock Options to Enhance Retention
- AN2 Therapeutics reports Q4 EPS (29c) vs (25c) last year
- AN2 Therapeutics Announces $40 Million Private Placement Financing
- AN2 Therapeutics to advance oral Epetraborole into Phase 2 study